CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovaria cancer...
Phase 1
Washington, District of Columbia, United States and 2 other locations
Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The study is pl...
Phase 3
Annapolis, Maryland, United States
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Towson, Maryland, United States and 213 other locations
bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...
Phase 3
Silver Spring, Maryland, United States and 22 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Baltimore, Maryland, United States and 125 other locations
(CAR) T cells developed by Precigen, Inc.) in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has...
Phase 1
Bethesda, Maryland, United States and 1 other location
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Glenn Dale, Maryland, United States and 46 other locations
(PK), and pharmacodynamics (PD) of ZN-c3 in combination with niraparib and of ZN-c3 Monotherapy in subjects with platinum-resistant ovarian ....
Phase 1, Phase 2
Fairfax, Virginia, United States and 19 other locations
of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian...
Phase 3
Silver Spring, Maryland, United States and 92 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Gainesville, Virginia, United States and 31 other locations
Clinical trials
Research sites
Resources
Legal